Thứ Bảy, 20 tháng 3, 2010

King Pharmaceuticals Settles and One Columnist Writes that Such Settlements are Not the Answer

›
Here we go again.  The latest settlement in the parade was made by the Alpharma subsidiary of King Pharmaceuticals, as reported by Reuters ...

Study: Researchers with Glaxo ties favored Avandia

›
As mentioned in my previous post on the MIT controversy surrounding an economist's testifying to Congress on healthcare policy without r...
Thứ Sáu, 19 tháng 3, 2010

Gruber at MIT to Senators: "I Promise To Be Good ... Next Time"

›
Frequently expressed on this blog are concerns about conflicts of interest and their corrosive effects upon healthcare ( query link ). We a...
Thứ Tư, 17 tháng 3, 2010

AMA And Almost 100 Physician Societies Sound Off To CMS On Health IT, Use "F" Word

›
In a remarkable development, the American Medical Association and nearly one hundred other physician specialty societies submitted a letter ...

A Simple Lesson for the Health IT Industry

›
From an Op Ed " Living with the Electronic Car " in today's Wall Street Journal: "A Toyota executive recently explained t...
Thứ Hai, 15 tháng 3, 2010

Abbott's TriCor Fails To Beat A Sugar Pill in Diabetics - And In Pharma's Current Death Spiral, Forget About a Drug That Will

›
In numerous national publications today, we are once again reminded that lowering the risk of diabetics for vascular events (MI/heart attack...

Third-Party Reviews of Medical Devices Come Under Scrutiny at the FDA - Except Healthcare IT Medical Devices, Which Get Special Accommodation

›
This WSJ article caught my eye: Third-Party Reviews of Devices Come Under Scrutiny at the FDA March 15, 2010 By ALICIA MUNDY and JARED A. FA...